Repurposable drugs for SARS-CoV-2 and influenza sepsis with scRNA-seq data targeting post-transcription modifications

Coronavirus disease 2019 (COVID-19) has impacted almost every part of human life worldwide, posing a massive threat to human health. The lack of time for new drug discovery and the urgent need for rapid disease control to reduce mortality have led to a search for quick and effective alternatives to...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Zhihan, Guo, Kai, Gao, Pan, Pu, Qinqin, Li, Changlong, Hur, Junguk, Wu, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694063/
https://www.ncbi.nlm.nih.gov/pubmed/34993416
http://dx.doi.org/10.1093/pcmedi/pbab022

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694063/
https://www.ncbi.nlm.nih.gov/pubmed/34993416
http://dx.doi.org/10.1093/pcmedi/pbab022

Ejemplares similares